TFRC and neoplasm: These results indicate that VISTA can specifically regulate the differentiation direction of CD4+CD25− T cells through Tfr cells, significantly promoting their differentiation toward the immunosuppressive Th2 subset while inhibiting the differentiation of the anti-tumor Th1 and Th17 subsets.